These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 36706843)
21. A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis. Pattarawat P; Hunt JT; Poloway J; Archibald CJ; Wang HR Cancer Chemother Pharmacol; 2021 Sep; 88(3):415-425. PubMed ID: 34043046 [TBL] [Abstract][Full Text] [Related]
22. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function. Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822 [TBL] [Abstract][Full Text] [Related]
23. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer. Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446 [TBL] [Abstract][Full Text] [Related]
24. Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer. Valcourt DM; Dang MN; Scully MA; Day ES ACS Nano; 2020 Mar; 14(3):3378-3388. PubMed ID: 32083466 [TBL] [Abstract][Full Text] [Related]
25. Molecular Engineering of an Organic NIR-II Fluorophore with Aggregation-Induced Emission Characteristics for In Vivo Imaging. Wu W; Yang Y; Yang Y; Yang Y; Zhang K; Guo L; Ge H; Chen X; Liu J; Feng H Small; 2019 May; 15(20):e1805549. PubMed ID: 30925013 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors. Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238 [TBL] [Abstract][Full Text] [Related]
27. Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types. Handgraaf HJM; Boonstra MC; Prevoo HAJM; Kuil J; Bordo MW; Boogerd LSF; Sibinga Mulder BG; Sier CFM; Vinkenburg-van Slooten ML; Valentijn ARPM; Burggraaf J; van de Velde CJH; Frangioni JV; Vahrmeijer AL Oncotarget; 2017 Mar; 8(13):21054-21066. PubMed ID: 28416744 [TBL] [Abstract][Full Text] [Related]
28. Song N; Zhao L; Zhu M; Zhao J Contrast Media Mol Imaging; 2019; 2019():9502712. PubMed ID: 31598115 [TBL] [Abstract][Full Text] [Related]
29. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer. Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269 [TBL] [Abstract][Full Text] [Related]
30. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer. Li M; Li A; Zhou S; Lv H; Yang W J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840 [TBL] [Abstract][Full Text] [Related]
31. Co-targeting Bulk Tumor and CSCs in Clinically Translatable TNBC Patient-Derived Xenografts via Combination Nanotherapy. Sulaiman A; McGarry S; El-Sahli S; Li L; Chambers J; Phan A; Côté M; Cron GO; Alain T; Le Y; Lee SH; Liu S; Figeys D; Gadde S; Wang L Mol Cancer Ther; 2019 Oct; 18(10):1755-1764. PubMed ID: 31308079 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis. Humphries B; Wang Z; Oom AL; Fisher T; Tan D; Cui Y; Jiang Y; Yang C Carcinogenesis; 2014 Oct; 35(10):2254-63. PubMed ID: 24925028 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer. Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252 [TBL] [Abstract][Full Text] [Related]
34. Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133 Brugnoli F; Grassilli S; Lanuti P; Marchisio M; Al-Qassab Y; Vezzali F; Capitani S; Bertagnolo V BMC Cancer; 2017 Sep; 17(1):617. PubMed ID: 28870198 [TBL] [Abstract][Full Text] [Related]
35. The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with Bouchard A; Sikner H; Baverel V; Garnier AR; Monterrat M; Moreau M; Limagne E; Garrido C; Kohli E; Collin B; Bellaye PS Cells; 2021 Dec; 10(12):. PubMed ID: 34943901 [TBL] [Abstract][Full Text] [Related]
36. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery. Tang C; Du Y; Liang Q; Cheng Z; Tian J Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075 [TBL] [Abstract][Full Text] [Related]
37. In Vivo Isolation of a Highly-aggressive Variant of Triple-negative Human Breast Cancer MDA-MB-231 Using Serial Orthotopic Transplantation. Yano S; Takehara K; Miwa S; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM Anticancer Res; 2016 Aug; 36(8):3817-20. PubMed ID: 27466482 [TBL] [Abstract][Full Text] [Related]
38. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer. Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625 [TBL] [Abstract][Full Text] [Related]
39. CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer. Wang Z; Sau S; Alsaab HO; Iyer AK Nanomedicine; 2018 Jun; 14(4):1441-1454. PubMed ID: 29678787 [TBL] [Abstract][Full Text] [Related]